Integra Lifesciences Holdings Corp
F:IL3
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
I
|
Integra Lifesciences Holdings Corp
F:IL3
|
US |
|
Halliburton Co
NYSE:HAL
|
US |
|
R
|
Realty Income Corp
F:RY6
|
US |
|
D
|
Dermapharm Holding SE
XMUN:DMP
|
DE |
Wall St Price Targets
IL3 Price Targets Summary
Integra Lifesciences Holdings Corp
According to Wall Street analysts, the average 1-year price target for IL3 is 12.73 EUR with a low forecast of 10.26 EUR and a high forecast of 20.57 EUR.
Price Targets
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.
What is IL3's stock price target?
Price Target
12.73
EUR
According to Wall Street analysts, the average 1-year price target for IL3 is 12.73 EUR with a low forecast of 10.26 EUR and a high forecast of 20.57 EUR.
What is the Revenue forecast for Integra Lifesciences Holdings Corp?
Projected CAGR
4%
Over the last 13 years, the compound annual growth rate for Revenue has been 5%. The projected CAGR for the next 3 years is 4%.
What is the Gross Profit forecast for Integra Lifesciences Holdings Corp?
Projected CAGR
8%
Over the last 13 years, the compound annual growth rate for Gross Profit has been 4%. The projected CAGR for the next 3 years is 8%.
What is the Operating Income forecast for Integra Lifesciences Holdings Corp?
Projected CAGR
24%
Over the last 13 years, the compound annual growth rate for Operating Income has been 3%. The projected CAGR for the next 3 years is 24%.
